As of 2025-03-21, the Relative Valuation of IGM Biosciences Inc (IGMS) is (89.57) USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.20 USD, the upside of IGM Biosciences Inc based on Relative Valuation is -7532.9%.
The range of the Relative Valuation is (71.06) - (102.34) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 21.6x - 36.8x | 29.2x |
| Forward P/E multiples | 19.3x - 31.1x | 25.2x |
| Fair Price | (71.06) - (102.34) | (89.57) |
| Upside | -5997.1% - -8593.2% | -7532.9% |
| Date | P/E |
| 2025-03-12 | -0.42 |
| 2025-03-11 | -0.42 |
| 2025-03-10 | -0.41 |
| 2025-03-07 | -0.40 |
| 2025-03-06 | -0.43 |
| 2025-03-05 | -0.41 |
| 2025-03-04 | -0.40 |
| 2025-03-03 | -0.38 |
| 2025-02-28 | -0.41 |
| 2025-02-27 | -0.41 |
| 2025-02-26 | -0.40 |
| 2025-02-25 | -0.40 |
| 2025-02-24 | -0.41 |
| 2025-02-21 | -0.42 |
| 2025-02-20 | -0.42 |
| 2025-02-19 | -0.46 |
| 2025-02-18 | -0.44 |
| 2025-02-14 | -0.43 |
| 2025-02-13 | -0.42 |
| 2025-02-12 | -0.42 |
| 2025-02-11 | -0.39 |
| 2025-02-10 | -0.42 |
| 2025-02-07 | -0.43 |
| 2025-02-06 | -0.46 |
| 2025-02-05 | -0.48 |
| 2025-02-04 | -0.48 |
| 2025-02-03 | -0.43 |
| 2025-01-31 | -0.46 |
| 2025-01-30 | -0.46 |
| 2025-01-29 | -0.45 |
| 2025-01-28 | -0.48 |
| 2025-01-27 | -0.50 |
| 2025-01-24 | -0.51 |
| 2025-01-23 | -0.52 |
| 2025-01-22 | -0.52 |
| 2025-01-21 | -0.52 |
| 2025-01-17 | -0.54 |
| 2025-01-16 | -0.56 |
| 2025-01-15 | -0.61 |
| 2025-01-14 | -0.52 |
| 2025-01-13 | -0.54 |
| 2025-01-10 | -0.63 |
| 2025-01-08 | -1.88 |
| 2025-01-07 | -2.07 |
| 2025-01-06 | -1.97 |
| 2025-01-03 | -1.99 |
| 2025-01-02 | -1.89 |
| 2024-12-31 | -1.86 |
| 2024-12-30 | -1.84 |
| 2024-12-27 | -1.93 |